Both the keynote and student speakers at the 2022 UC Berkeley doctoral commencement ceremony are bioengineers! Recent PhD alumna Sally Winkler, now a research scientist at AbbVie, will give the student address, and Ann Lee-Karlon, BS alumna and COO of Altos Labs, will deliver the keynote. The ceremony on May 18 will be webcast live.
Congratulations to FIFTEEN new NSF Graduate Research Fellows! Among the winners are: current PhD students: Deniz Akpinaroglu, Joana Cabrera, Joy Chen, Benjamin Lesch, Alvince Pongos, Caleb Rux, Gabriel Sturm, and Jazmin Velazquez; incoming PhD students Maple Chen, Russell Ro and Esther Sim; graduating undergrads Joyce Chen and Carolina Rios-Martinez;
Glyphic Biotechnologies, founded by BioE alumnus Joshua Young Yang, is one of three winners of QIAGEN’s new Biotech Grants program. Glyphic is developing a first-of-its-kind, next-generation sequencing platform for proteins.
BioE alumna Michelle Khine, biomedical engineering professor and associate dean for the Division of Undergraduate Education at UC Irvine, has been named one of six inaugural Samueli Scholars by the Susan Samueli Integrative Health Institute.
Master of Translational Medicine alumnus Steve Lee has been named to the Forbes 2022 30 Under 30 list in the social impact category! Steve and his brother Daniel founded Aura, an app that offers wellness and mental health coaching and resources.
Alumna Tammy Hsu is finding a way to produce fabric dye with a lower environmental impact – feature article in Nature online.
Congratulations BioE startup Huue and founder PhD alumna Tammy Hsu! Huue’s process for creating environmentally friendly indigo dye through synthetic biology has been named one of Time Magazine’s Best Inventions of 2021.
Congratulations Nathanial Huebsch, BS BioE 2003, now Assistant Professor of Biomedical Engineering at Washington University in St. Louis. Huebsch has been named a 2021 Young Innovator by Cellular and Molecular Bioengineering!
Alumni-founded company Lygos is featured in the Wall Street Journal for their efforts to produce targeted cannabinoid compounds through synthetic biology.